Form 4: Hims & Hers COO Michael Chi Reports RSU Vesting, Tax Withholding

Hims & Hers Health, Inc. Chief Operating Officer Michael Chi reported the vesting and settlement of Restricted Stock Units and associated tax withholdings.

Summary

• Michael Chi, Chief Operating Officer of Hims & Hers Health, Inc. (HIMS), reported transactions involving Class A Common Stock and Restricted Stock Units (RSUs) on March 13, 2026.
• 198,542 shares of Class A Common Stock were withheld by the issuer at $24.77 per share to cover tax withholding obligations related to performance RSUs that vested on February 23, 2026.
• An additional 39,214 shares of Class A Common Stock were withheld by the issuer at $24.77 per share for tax withholding obligations connected to the vesting and settlement of other RSUs.
• 72,108 shares of Class A Common Stock were acquired through the exercise/conversion of derivative securities (RSUs) on the same date.
• Following these transactions, Michael Chi directly beneficially owns 504,571 shares of Class A Common Stock.
• Several tranches of RSUs were converted into Class A Common Stock on March 13, 2026, including 9,357, 16,495, 16,298, 19,359, and 10,599 units, all at an exercise price of $0.
• The RSUs are subject to service-based vesting over a 4-year period in substantially equal quarterly installments, with various initial vesting dates ranging from June 15, 2022, to June 15, 2025.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. While shares were disposed for tax, the underlying RSU vesting indicates continued executive tenure and a routine compensation event, which is generally expected and not indicative of negative company performance.

Positives

• The vesting of Restricted Stock Units indicates the fulfillment of service-based requirements by the Chief Operating Officer, reflecting continued tenure and contribution to the company.
• The acquisition of 72,108 shares through RSU conversion increases the COO's direct ownership in the company, aligning his interests with shareholders.

Negatives

• The disposition of 237,756 shares (198,542 + 39,214) to cover tax withholding obligations represents a reduction in the COO's direct shareholding that is not a voluntary sale.

Risks

• No specific risks are mentioned in this Form 4 filing beyond the inherent risks associated with equity compensation and tax obligations.

Future Outlook

The filing details the vesting schedule for various tranches of Restricted Stock Units, indicating future quarterly vesting events based on service requirements through at least June 15, 2025.

Management Comments

• No direct quotes or paraphrased statements from company management are provided in this Form 4 filing, which is a standard report of insider transactions.

Industry Context

StockSavvy.ai notes that RSU vesting and subsequent tax-related share withholdings are common occurrences for executives in publicly traded companies, particularly in growth-oriented sectors like telehealth and consumer health, where equity compensation forms a significant part of executive remuneration. This filing reflects a routine compensation event rather than a strategic shift or market-moving development.

Comparison to Industry Standards

• StockSavvy.ai finds that the structure of service-based Restricted Stock Units vesting over a four-year period with quarterly installments is a standard practice for executive compensation across various industries, including technology and healthcare.
• Companies like Teladoc Health (TDOC) and Amwell (AMWL) also utilize similar long-term equity incentive plans to retain key talent and align executive interests with long-term shareholder value.
• The withholding of shares for tax purposes upon vesting is also a standard, non-discretionary mechanism to satisfy statutory tax obligations, comparable to practices at companies such as Amazon (AMZN) or Microsoft (MSFT) for their executives' equity awards.

Related Party Transactions

• The transactions involve the Chief Operating Officer and the issuer (Hims & Hers Health, Inc.), which are considered related parties in the context of executive compensation and equity awards.

Stakeholder Impact

• Shareholders: The vesting and subsequent tax-related share disposition by a key executive could be seen as a routine event, with minimal direct impact on the company's operational performance or strategic direction. The increase in direct ownership through RSU conversion aligns executive interests with shareholders.
• Employees: The RSU vesting demonstrates the company's commitment to its equity compensation plans, which can positively influence employee morale and retention, especially for those with similar equity awards.

Next Steps

• Continued vesting of remaining Restricted Stock Units in substantially equal quarterly installments on Company Quarterly Vesting Dates (March 15, June 15, September 15, and December 15) through at least June 15, 2025.

Key Dates

Recommendation

This Form 4 filing reports routine RSU vesting and tax-related share withholdings for a key executive. Such transactions are standard compensation events and do not typically signal a change in the company's fundamental outlook or operational performance. Therefore, a 'hold' recommendation is appropriate as this filing provides no new information to alter an existing investment thesis, nor does it suggest any immediate catalysts for significant price movement.

Keywords

Hims & Hers Health, HIMS, Michael Chi, Chief Operating Officer, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Stock Compensation, Tax Withholding, Equity Ownership